Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Challenging the IP Protection Framework
Over 100 MEPs call for a TRIPS Waiver
Access to Medicines in Europe
Health Action International at 40 – A Word from Executive Director, Tim Reed
There is no UHC without Universal Medicines Coverage
HAI’s Great Health Hack Delivers Great Ideas for Access to Meds
Pharmaceutical promotion: how does it impact rational use of medicine?
Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic
What do the next five years have in store for the European Medicines Agency?
Dutch institutions failing to register results of clinical trials
The significant impact of Health Technology Assessment discussions on national health systems
COVID-19 risks turning back the clock on years of essential development work
Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya
HAI Releases Annual Report 2019
Clinical trials and COVID-19
Reflections on the World Health Assembly
COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
Health Technology Assessments: will 2020 end the deadlock?
Is clinical trial transparency under threat?
A Momentous Week for Access to Medicines
Lack of access to ICEMs has disastrous consequences for many. So what’s being done?
Access to ICEMs is a fundamental human right, but millions aren’t receiving them
Civil Society Voice at International Summit to Tackle Global Health Challenge of Antimicrobial Resistance
Dr Marg Ewen Receives the Helen Clark-JoPPP Award